Search Results - "Jacquemin, Marc G."

Refine Results
  1. 1

    Factor VIII-Fc Activates Natural Killer Cells via Fc-Mediated Interactions With CD16 by Lagassé, H.A. Daniel, Hopkins, Louis B., Jankowski, Wojciech, Jacquemin, Marc G., Sauna, Zuben E., Golding, Basil

    Published in Frontiers in immunology (28-06-2021)
    “…The most challenging complication associated with Factor VIII (FVIII) replacement therapy is the development of neutralizing anti-drug antibodies, or…”
    Get full text
    Journal Article
  2. 2

    Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors by Carlier, Vincent A, VanderElst, Luc, Janssens, Wim, Jacquemin, Marc G, Saint-Remy, Jean-Marie R

    Published in PloS one (09-10-2012)
    “…The nature of MHC class II-binding epitopes not only determines the specificity of T cell responses, but may also alter effector cell functions. Cytolytic CD4+…”
    Get full text
    Journal Article
  3. 3

    Antigenicity of putative phospholipid membrane-binding residues in factor VIII by Barrow, Rachel T., Healey, John F., Jacquemin, Marc G., Saint-Remy, Jean-Marie R., Lollar, Pete

    Published in Blood (01-01-2001)
    “…Most inhibitory antibodies to human factor VIII (fVIII) bind to epitopes in the A2, ap-A3, or C2 domains. The anticoagulant action of antibodies to the C2…”
    Get full text
    Journal Article
  4. 4
  5. 5

    CD4+CD25+ T Cells Lyse Antigen-Presenting B Cells by Fas-Fas Ligand Interaction in an Epitope-Specific Manner by Janssens, Wim, Carlier, Vincent, Wu, Bo, VanderElst, Luc, Jacquemin, Marc G, Saint-Remy, Jean-Marie R

    Published in The Journal of immunology (1950) (01-11-2003)
    “…Suppression by regulatory T cells is now acknowledged to play a key role in the down-regulation of T cell responses to foreign and self Ags. In addition to the…”
    Get full text
    Journal Article
  6. 6

    In vivo neutralization of a C2 domain–specific human anti–Factor VIII inhibitor by an anti-idiotypic antibody by Gilles, Jean Guy G., Grailly, Sabrina C., De Maeyer, Marc, Jacquemin, Marc G., VanderElst, Luc P., Saint-Remy, Jean-Marie R.

    Published in Blood (01-04-2004)
    “…Factor VIII (FVIII) administration elicits specific inhibitory antibodies (Abs) in about 25% of patients with hemophilia A. The majority of such Abs reacts…”
    Get full text
    Journal Article
  7. 7

    Factor VIII alloantibodies in hemophilia by Jacquemin, Marc G, Saint-Remy, Jean-Marie R

    Published in Current opinion in hematology (01-05-2004)
    “…PURPOSE OF REVIEWThe development of an inhibitory response to factor VIII (FVIII) remains a puzzling challenge both for clinicians and scientists, not to…”
    Get full text
    Journal Article
  8. 8

    The Dermatophagoides pteronyssinus Group 2 Allergen Contains a Universally Immunogenic T Cell Epitope by Wu, Bo, Elst, Luc Vander, Carlier, Vincent, Jacquemin, Marc G, Saint-Remy, Jean-Marie R

    Published in The Journal of immunology (1950) (01-09-2002)
    “…The use of T cell epitope-containing peptides for the induction of anergy in allergen sensitization is limited by genetic restriction that could be…”
    Get full text
    Journal Article
  9. 9

    Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes by Gilles, J G, Lavend'homme, R, Peerlinck, K, Jacquemin, M G, Hoylaerts, M, Jorieux, S, Mazurier, C, Vermylen, J, Saint-Remy, J M

    Published in Thrombosis and haemostasis (01-07-1999)
    “…A mild haemophilia A patient (LE) with an Arg2150His mutation in the C1 domain of the factor VIII (FVIII) light chain was shown to have anti-FVIII antibodies…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    A Limited Number of Anti-Idiotypic Antibodies Is Required To Maintain FVIII Function in Presence of Polyclonal Anti-FVIII Antibodies of Haemophilia A Patients with Inhibitors by Gilles, Jean Guy G., Grailly, Sabrina E., Jacquemin, Marc G., Saint-Remy, Jean Marie M.

    Published in Blood (16-11-2006)
    “…Replacement therapy using either plasma-derived or recombinant FVIII elicits FVIII-specific Abs in about 25% of the patients. The majority of such antibodies…”
    Get full text
    Journal Article
  13. 13

    Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A by Peerlinck, Kathelijne, Jacquemin, Marc G., Arnout, Jef, Hoylaerts, Marc F., Gilles, Jean Guy G., Lavend’homme, Renaud, Johnson, Karen M., Freson, Kathleen, Scandella, Dorothea, Saint-Remy, Jean-Marie R., Vermylen, Jos

    Published in Blood (01-04-1999)
    “…Two unrelated patients with the same Arg2150His mutation in the factor VIII (FVIII) C1 domain, a residual FVIII activity of 0.09 IU/mL, and inhibitor titres of…”
    Get full text
    Journal Article
  14. 14

    Immune Tolerance Induction by High Doses FVIII in Hemophilia A Patients with Inhibitor Does Not Require Deletion of FVIII-Specific T Cells by Jacquemin, Marc G., Lavend'homme, Renaud, Tinot, Thérèse, Peerlinck, Kathelijne, Saint-Remy, Jean Marie, Pautard, Brigitte

    Published in Blood (16-11-2006)
    “…In patients with hemophilia A and FVIII inhibitor, tolerance to FVIII can frequently be restored by prolonged administration of FVIII (immune tolerance…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    The Determination of the Inhibitory Activity of Some Factor VIII Type II Inhibitor Antibodies Is Biased by the Type of Factor VIII Assay by Jacquemin, Marc G., Lamprecht, Seb, Lavend'homme, Renaud, Roodt, Jan, Chatelain, Bernard, Deneys, Veronique, Dewaele, Jeroen, Stassen, Jean-Marie, Meiring, Muriel, Saint-Remy, Jean Marie, Pieters, Henry, Badenhorst, Philip

    Published in Blood (16-11-2005)
    “…Although type II Factor VIII (FVIII) inhibitor antibodies inhibit only partially FVIII activity, even when such antibodies are in very large excess over FVIII,…”
    Get full text
    Journal Article
  19. 19

    Rupture of T Cell Tolerance to Self Factor VIII in Mild/Moderate Hemophilia A by Jacquemin, Marc G., Lavend'homme, Renaud, Abdellah, Benhida, Peerlinck, Kathelijne, Vermylen, Jos, Deneys, Véronique, Saint-Remy, Jean-Marie, Hermans, Cédric

    Published in Blood (16-11-2004)
    “…Some patients with mild/moderate hemophilia A develop anti-Factor VIII (FVIII) antibodies following treatment with FVIII. In rare cases, the patient antibodies…”
    Get full text
    Journal Article
  20. 20

    Major T cell epitope‐containing peptides can elicit strong antibody responses by Wu, Bo, Toussaint, Gaëlle, Vander Elst, Luc, Granier, Claude, Jacquemin, Marc G., Saint‐Remy, Jean‐Marie R.

    Published in European journal of immunology (01-01-2000)
    “…Peptides containing major T cell epitopes have the capacity to induce T cell anergy and have therefore been proposed for the treatment of allergic and…”
    Get full text
    Journal Article